- Home
- CLNN vs IXHL Comparison
CLNN vs IXHL Comparison
Compare CLNN & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLNN | IXHL |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 134.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CLNN | IXHL |
|---|---|---|
| Price | $5.16 | $0.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $32.67 | N/A |
| AVG Volume (30 Days) | 96.2K | ★ 9.2M |
| Earning Date | 11-13-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $214,000.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $92.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.28 | $0.08 |
| 52 Week High | $13.50 | $2.25 |
Technical Indicators
Market Signals| Indicator | CLNN | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 46.98 |
| Support Level | $4.50 | $0.38 |
| Resistance Level | $6.68 | $0.41 |
| Average True Range (ATR) | 0.61 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 31.06 | 49.00 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.